These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8385783)
1. Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin. Winter JC; Rabin RA Pharmacol Biochem Behav; 1993 Apr; 44(4):851-5. PubMed ID: 8385783 [TBL] [Abstract][Full Text] [Related]
2. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. Winter JC; Rabin RA J Pharmacol Exp Ther; 1992 Nov; 263(2):682-9. PubMed ID: 1359109 [TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190. Barrett JE; Gleeson S Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937 [TBL] [Abstract][Full Text] [Related]
4. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD; Neill J; Kidd EJ; Fozard JR Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin. Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133 [TBL] [Abstract][Full Text] [Related]
6. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [TBL] [Abstract][Full Text] [Related]
7. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896 [TBL] [Abstract][Full Text] [Related]
8. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers. Oksenberg D; Peroutka SJ Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358 [TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences. Kleven MS; Koek W J Pharmacol Exp Ther; 1998 Jan; 284(1):238-49. PubMed ID: 9435184 [TBL] [Abstract][Full Text] [Related]
10. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide. Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497 [TBL] [Abstract][Full Text] [Related]
12. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons. Ahlers ST; Weissman BA; Barrett JE J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359 [TBL] [Abstract][Full Text] [Related]
13. Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine. Winter JC Pharmacol Biochem Behav; 1988 Jan; 29(1):193-5. PubMed ID: 2895479 [TBL] [Abstract][Full Text] [Related]
14. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin. Rabin RA; Winter JC Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905 [TBL] [Abstract][Full Text] [Related]
15. Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission. Claustre Y; Rouquier L; Serrano A; Bénavidès J; Scatton B Eur J Pharmacol; 1991 Oct; 204(1):71-7. PubMed ID: 1666563 [TBL] [Abstract][Full Text] [Related]
16. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Chojnacka-Wójcik E Pol J Pharmacol Pharm; 1992; 44(2):135-46. PubMed ID: 1357637 [TBL] [Abstract][Full Text] [Related]
17. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors. Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623 [TBL] [Abstract][Full Text] [Related]
18. 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists. Moore NA; Rees G; Sanger G; Perrett L Pharmacol Biochem Behav; 1993 Sep; 46(1):141-3. PubMed ID: 8255903 [TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor blockade in rats enhances the ambulation induced by 5-HT1A receptor agonists. Kalkman HO Eur J Pharmacol; 1989 Dec; 173(2-3):121-5. PubMed ID: 2576226 [TBL] [Abstract][Full Text] [Related]
20. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]